CAMBRIDGE INNOVATION CAPITAL

• 64209 - Activities of other holding companies n.e.c.

At Spirea, we are revolutionising healthcare with our unique multivalent ELIVATE linker technology. Our mission is to enable next generation ADCs that address critical unmet needs in oncology and other diseases... ErebaGen is a biotechnology company that harnesses the reservoir of biocatalysts developed over millions of years of evolution by Nature. Our innovative approach accelerates development and enables cost-effective, large-scale production for greener, more sustainable manufacturing solutions... At Awen Oncology, we aim to transform the landscape of cancer treatment. Delivering first-in-class therapeutics that target novel, undrugged cancer-specific factors, offering new hope for patients around the world.

Also known as: Awen Oncology, CAMBRIDGE INNOVATION CAPITAL LIMITED, Spirea, Start Codon

Registration numbers: 08243718 (CH)

VAT numbers: GB173 7960 72

Primary location: Cambridge United Kingdom